{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:24:19Z","timestamp":1791923059803,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.neo.2024.101120","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T10:20:36Z","timestamp":1735381236000},"page":"101120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["RUNX2 enhances bladder cancer progression by promoting glutamine metabolism"],"prefix":"10.1016","volume":"60","author":[{"given":"Zhigang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoju","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quansen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2024.101120_bib0001","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.neo.2024.101120_bib0002","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.neo.2024.101120_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24129854","article-title":"Epigenetic and immunological features of bladder cancer","volume":"24","author":"Gilyazova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2024.101120_bib0004","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.neo.2024.101120_bib0005","first-page":"11536","article-title":"Advanced\/metastatic bladder cancer: current status and future directions","volume":"24","author":"Facchini","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.neo.2024.101120_bib0006","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","article-title":"Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression","volume":"73","author":"Li","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.neo.2024.101120_bib0007","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.neo.2024.101120_bib0008","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","article-title":"Targeting glutamine metabolism as a therapeutic strategy for cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neo.2024.101120_bib0009","first-page":"2189","article-title":"Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis","volume":"44","author":"Sun","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neo.2024.101120_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101340","article-title":"Long noncoding RNA UCA1 promotes glutamine-driven anaplerosis of bladder cancer by interacting with hnRNP I\/L to upregulate GPT2 expression","volume":"17","author":"Zhao","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.neo.2024.101120_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12060558","article-title":"Metabolic profiling of bladder cancer patients' serum reveals their sensitivity to neoadjuvant chemotherapy","volume":"12","author":"Zhuang","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.neo.2024.101120_bib0012","article-title":"RUNX2 and Cancer","volume":"24","author":"Lin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2024.101120_bib0013","article-title":"RUNX2 promotes gastric cancer progression through the transcriptional activation of MGAT5 and MMP13","volume":"13","author":"Wang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neo.2024.101120_bib0014","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2016.06.007","article-title":"RUNX2 promotes breast cancer bone metastasis by increasing integrin alpha5-mediated colonization","volume":"380","author":"Li","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neo.2024.101120_bib0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/PAI.0000000000000193","article-title":"High coexpression of runt-related transcription factor 2 (RUNX2) and p53 independently predicts early tumor recurrence in bladder urothelial carcinoma patients","volume":"24","author":"Abdelzaher","year":"2016","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.neo.2024.101120_bib0016","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/jcb.25171","article-title":"The RUNX2 transcription factor negatively regulates SIRT6 expression to alter glucose metabolism in breast cancer cells","volume":"116","author":"Choe","year":"2015","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.neo.2024.101120_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111110","article-title":"CENPA promotes glutamine metabolism and tumor progression by up-regulating SLC38A1 in endometrial cancer","volume":"117","author":"Li","year":"2024","journal-title":"Cell Signal."},{"key":"10.1016\/j.neo.2024.101120_bib0018","doi-asserted-by":"crossref","first-page":"D39","DOI":"10.1093\/nar\/gkac907","article-title":"AnimalTFDB 4.0: a comprehensive animal transcription factor database updated with variation and expression annotations","volume":"51","author":"Shen","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neo.2024.101120_bib0019","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1002\/cam4.5412","article-title":"Metabolism-related lncRNAs signature to predict the prognosis of colon adenocarcinoma","volume":"12","author":"Sun","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.neo.2024.101120_bib0020","first-page":"6588","article-title":"TGF-beta downstream of Smad3 and MAPK signaling antagonistically regulate the viability and partial epithelial-mesenchymal transition of liver progenitor cells","volume":"16","author":"Sun","year":"2024","journal-title":"Aging"},{"key":"10.1016\/j.neo.2024.101120_bib0021","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2022.12697","article-title":"Aspirin attenuates liver fibrosis by suppressing TGF\u2011beta1\/Smad signaling","volume":"25","author":"Sun","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neo.2024.101120_bib0022","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/pro.3987","article-title":"The Human Protein Atlas-Spatial localization of the human proteome in health and disease","volume":"30","author":"Digre","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.neo.2024.101120_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145451","article-title":"Cancer-associated fibroblasts and the related Runt-related transcription factor 2 (RUNX2) promote bladder cancer progression","volume":"775","author":"Liu","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.neo.2024.101120_bib0024","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neo.2024.101120_bib0025","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.bbamcr.2015.12.017","article-title":"Glutamine transporters in mammalian cells and their functions in physiology and cancer","volume":"1863","author":"Bhutia","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neo.2024.101120_bib0026","first-page":"207","article-title":"Glutamine transporters as pharmacological targets: From function to drug design","volume":"15","author":"Scalise","year":"2020","journal-title":"Asian J. Pharm Sci."},{"key":"10.1016\/j.neo.2024.101120_bib0027","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41419-023-06050-1","article-title":"Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neo.2024.101120_bib0028","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/hep.29183","article-title":"A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis","volume":"66","author":"Liu","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.neo.2024.101120_bib0029","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2024.101120_bib0030","article-title":"New progress of glutamine metabolism in the occurrence, development, and treatment of ovarian cancer from mechanism to clinic","volume":"12","author":"Yang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neo.2024.101120_bib0031","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41419-022-05079-y","article-title":"Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neo.2024.101120_bib0032","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1080\/01635581.2023.2166540","article-title":"LncRNA PVT1 confers cisplatin resistance of esophageal cancer cells through modulating the mir-181a-5p-glutaminase (GLS) axis","volume":"75","author":"Chen","year":"2023","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.neo.2024.101120_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.100967","article-title":"RUNX2 prompts triple negative breast cancer drug resistance through TGF-beta pathway regulating breast cancer stem cells","volume":"48","author":"Lv","year":"2024","journal-title":"Neoplasia"}],"updated-by":[{"DOI":"10.1016\/j.neo.2026.101373","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000}}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624001611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624001611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:08:45Z","timestamp":1741082925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558624001611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":33,"alternative-id":["S1476558624001611"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2024.101120","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RUNX2 enhances bladder cancer progression by promoting glutamine metabolism","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2024.101120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101120"}}